Kantar Health Blog

Lynnette Cooke

Lynnette Cooke

Global CEO

Our Global CEO, Lynnette Cooke, is a strong advocate for the preservation of evidence-based research standards who embraces innovative technologies in the pursuit of bringing the world better health.

Otávio Clark

Otávio Clark

CEO and Team Leader, Evidências

Otávio Clark is an oncologist with fellowship in Evidence-Based Oncology and Research Methods. He is an expert in evidence-based medicine, pharmacoeconomics, health technology assessments (HTA) and market access.

Arnold DuBell

Arnold DuBell

Senior Consultant, Clinical & Scientific Assessment

Arnold DuBell, Ph.D., M.B.A. is a thought leader with broad experience in and knowledge of the global oncology pharmaceutical market, especially current and emerging treatment patterns.

Michael Fronstin

Michael Fronstin

GM, Health Outcomes, Epidemiology & Forecasting

Michael Fronstin is an expert in translating patient-reported outcomes, behaviors and attitudes into actionable recommendations for the pharma industry.

Richard Goosey

Richard Goosey

Chief Methodologist

Richard Goosey is a Chief Methodologist at Kantar Health in the UK. He speaks regularly at industry events on innovation and has particular interests in data collection and understanding how decisions are made.

Vince Grillo

Vince Grillo

General Manager Regional Hub – Singapore

Vince Grillo, PhD., has more than 20 years’ experience in market insight-led consultancy. He partners with clients across strategic function to help them achieve financial, operational, organizational competencies and targets.

Jay Grisolano

Jay Grisolano

Senior Director, Clinical & Scientific Assessment

Jay Grisolano, Ph.D., is a thought leader with broad experience in and knowledge of the global oncology pharmaceutical market, especially current and emerging treatment patterns.

Tom Haskell

Tom Haskell

Global Head of Data Analytics

Tom Haskell leads Kantar Health’s efforts to develop differentiating offerings by incorporating secondary healthcare data with Kantar Health’s current data sources. He focuses on finding creative solutions for the pharma/biotech space.

Stephanie Hawthorne

Stephanie Hawthorne

Vice President, Clinical & Scientific Assessment

Stephanie Hawthorne, Ph.D., is a thought leader with broad experience in and knowledge of the global oncology pharmaceutical market, especially current and emerging treatment patterns.

Jeanette Hodgson

Jeanette Hodgson

Global Head of Qualitative Strategy

Jeanette has 25 years’ experience of global, strategic market research and consultancy, primarily in the healthcare sector. She has business leadership experience and is a trained Master NLP practitioner as well as specialist qualitative researcher.

Tim Irfan

Tim Irfan

Associate Director, MI Germany

Tim Irfan actively works with global pharmaceutical companies in order to grow their business. His focus is on the strategic brand management and he is an expert in translating insights into meaningful and actionable recommendations for the brand teams.

Junghwa Lee

Junghwa Lee

GM, Kantar Health S. Korea

Junghwa Lee is a pharma industry veteran who leads Kantar Health’s research and consulting business in South Korea.

Mark Sales

Mark Sales

Head of Brand & Stakeholder Management

Mark Sales has worked with most of the world’s leading healthcare brands and is an industry expert in brand marketing, stakeholder management, the new commercial model and digital healthcare programs.

Jessica Santos, Ph.D.

Jessica Santos, Ph.D.

Global Compliance and Quality Director

Jessica Santos, Ph.D., is responsible for coordinating all activities related to compliance laws, guidelines, and pharmacovigilance and drives Kantar Health’s quality strategy.

Aleš Tichopad

Aleš Tichopad

Director, CEEOR

Aleš Tichopad, Ph.D., has been engaged in clinical and late-phase drug research for various CROs since 2003. In 2006 he co-founded CEEOR, now a part of Kantar Health, where he leads the health economics consulting team and commercial effectiveness business.

Indira Umareddy

Indira Umareddy

Director of RWE & Market Access, APMEA

Indira Umareddy, PhD, MPH, is an expert in Real World Evidence and Market Access with extensive experience in the healthcare industry in Asia, the Middle East and Europe

Linda VerPlanck

Linda VerPlanck

MD, Kantar Health Germany

Linda VerPlanck helps global clients meet and exceed their business needs in both established and emerging markets. She has particular interest and expertise in Latin American healthcare markets.

Debbie Warner

Debbie Warner

Vice President, Oncology Commercial Strategies

Debbie Warner is a strategic marketing leader with payer expertise in the oncology market. Her expertise includes both the U.S. and EU5 markets.

Colleen Welsh-Allen

Colleen Welsh-Allen

Vice President, Qualitative Research

Colleen Welsh-Allen RN, has over 15 years of experience in market research and leads business development and innovation for qualitative services.